NCT01734915View on ClinicalTrials.gov

Detecting EGFR T790M Mutations From Circulating Tumor Cells

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Non Small Cell Lung Cancer
Interventions
DEVICE

Circulating tumor cell chip

three tubes (6 teaspoons) of peripheral blood are drawn and are analyzed using the CTC chip

Trial Locations (4)

10065

Memorial Sloan Kettering Cancer Center, New York

77030

MD Anderson Cancer Center, Houston

02115

Massachusetts General Hospital, Boston

02215

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

lead

Massachusetts General Hospital

OTHER

NCT01734915 - Detecting EGFR T790M Mutations From Circulating Tumor Cells | Biotech Hunter | Biotech Hunter